BJDX
NASDAQ HealthcareBluejay Diagnostics, Inc. - Common Stock
Medical Devices
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
�� 市场数据
| 价格 | $4.34 |
|---|---|
| 成交量 | 73,984,668 |
| 市值 | 4.49M |
| RSI（14日） | 93.2 超买 |
| 200日均线 | $4.20 |
| 50日均线 | $1.95 |
| 52周最高 | $16.68 |
| 52周最低 | $1.62 |
| Forward P/E | -13.56 |
| Price / Book | 1.07 |
🎯 投资策略评分
BJDX 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (99/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🔪 Falling Knife (10/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 BJDX in your text
粘贴任何文章、记录或帖子 — 工具将提取 BJDX 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-06-02.